Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP621536.RA1mayz_RGydov7_w_F41IY2jJ0VUrNz6bk_N51zlx2jA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP621536.RA1mayz_RGydov7_w_F41IY2jJ0VUrNz6bk_N51zlx2jA130_assertion type Assertion NP621536.RA1mayz_RGydov7_w_F41IY2jJ0VUrNz6bk_N51zlx2jA130_head.
- NP621536.RA1mayz_RGydov7_w_F41IY2jJ0VUrNz6bk_N51zlx2jA130_assertion description "[Here, we used low-density arrays, quantitative PCR, and western blotting to determine how HER2 signaling inhibition with lapatinib or PI3K inhibitors affects the expression of genes involved in breast cancer metastatic spread and overall prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621536.RA1mayz_RGydov7_w_F41IY2jJ0VUrNz6bk_N51zlx2jA130_provenance.
- NP621536.RA1mayz_RGydov7_w_F41IY2jJ0VUrNz6bk_N51zlx2jA130_assertion evidence source_evidence_literature NP621536.RA1mayz_RGydov7_w_F41IY2jJ0VUrNz6bk_N51zlx2jA130_provenance.
- NP621536.RA1mayz_RGydov7_w_F41IY2jJ0VUrNz6bk_N51zlx2jA130_assertion SIO_000772 20126311 NP621536.RA1mayz_RGydov7_w_F41IY2jJ0VUrNz6bk_N51zlx2jA130_provenance.
- NP621536.RA1mayz_RGydov7_w_F41IY2jJ0VUrNz6bk_N51zlx2jA130_assertion wasDerivedFrom befree-20150227 NP621536.RA1mayz_RGydov7_w_F41IY2jJ0VUrNz6bk_N51zlx2jA130_provenance.
- NP621536.RA1mayz_RGydov7_w_F41IY2jJ0VUrNz6bk_N51zlx2jA130_assertion wasGeneratedBy ECO_0000203 NP621536.RA1mayz_RGydov7_w_F41IY2jJ0VUrNz6bk_N51zlx2jA130_provenance.